Clinical trials
Withdrawn Phase 1/2 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Baylor Research Institute | 1 |
| Cancer Research UK | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| GlyPharma Therapeutics | 1 |
| Kahr Medical | 1 |
| Louisiana State University Health Sciences Center Shreveport | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 21 |
| Leukemia | 6 |
| Lymphoma, Follicular | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Burkitt Lymphoma | 3 |
| Congenital Abnormalities | 3 |
| Hodgkin Disease | 3 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.